Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.3699
Delayed Data
As of Jul 27
 -0.0023 / -0.62%
Today’s Change
0.29
Today|||52-Week Range
1.33
-68.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues9.7M9.5M6.7M18.8M
 
 
 
 
 
Cost of Goods Sold4.4M4.5M3.4M9.1M
 
 
 
 
 
Depreciation And Amortization234.0K223.0K464.0K614.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.1M4.8M2.8M9.1M
 
 
 
 
 
General Expenses18.8M18.6M19.7M21.0M
 
 
 
 
 
Research And Development13.9M14.2M15.2M16.3M
 
 
 
 
 
Total Operating Expenses23.4M23.3M23.6M30.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.8M-13.8M-16.9M-11.9M
 
 
 
 
 
Other Expenses0.000.00-14.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.7M-13.2M-16.8M-11.9M
 
 
 
 
 
Preferred Dividend-1.4M-1.4M-1.4M-1.0M
 
 
 
 
 
Net Income-13.7M-13.2M-16.8M-11.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS197.3M203.9M227.4M236.9M
 
 
 
 
 
Shares To Calculate EPS Diluted197.3M203.9M227.4M236.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.07-$0.08-$0.05
 
 
 
 
 
EPS Diluted-$0.08-$0.07-$0.08-$0.05